All posts by: Michael Zand

About Michael Zand

‘Suicide molecule’ could lead to fail-safe cancer therapy, scientists say – Times & Star

Continue reading

2017-10-20 NEWS

Times & Star

‘Suicide molecule’ could lead to fail-safe cancer therapy, scientists say
Times & Star
Immunotherapy treatment had been partially successful because it is geared towards activating one of nature’s anti-cancer mechanisms, said Prof Peter. However, few cancers responded to immunotherapy and only a few patients benefited. He added: “Our …

and more »

Continue reading

2017-10-20 NEWS

California moves against unlicensed stemcell treatments — but is it doing enough?
Los Angeles Times
Unlicensed stemcell treatments aren’t innocuous — some have resulted in permanent injury to customers. Among other cases, three elderly women were reported this year to have lost all or part of their vision after a “stemcell” solution was injected

Continue reading

2017-10-20 NEWS

California moves against unlicensed stemcell treatments — but is it doing enough?
Los Angeles Times
Unlicensed stemcell treatments aren’t innocuous — some have resulted in permanent injury to customers. Among other cases, three elderly women were reported this year to have lost all or part of their vision after a “stemcell” solution was injected

Continue reading

2017-10-20 NEWS

CAR-T immunotherapy now approved for certain adult lymphoma patients
Medical Xpress
The Food and Drug Administration (FDA) has approved a breakthrough cancer therapy known as CAR-T for use in adults with advanced lymphoma. The therapy uses a patient’s own white blood cells, which are modified in a lab and re-trained to recognize …

and more »

Continue reading

2017-10-20 NEWS

WBUR

For Some, Cutting-Edge ‘CART‘ Treatment Unleashes ‘Pac-Man’ Cells Against Blood Cancer
WBUR
This week, the U.S. Food and Drug Administration approved the second therapy in this class, called Yescarta, to treat advanced B-cell lymphomas, like Wilkins’. The first CART drug, Kymriah, received approval in August to treat an advanced form of
New CART cell therapy offers effective option for certain blood cancer patientsNews-Medical.net
CART could revolutionize cancer treatment. It can also be fatalMassive
Personalized Gene Therapy Shows Promise For Certain Blood CancersCBS Miami

all 7 news articles »

Continue reading

2017-10-20 NEWS

Boston Herald

CAR-T immunotherapy may help blood cancer patients who don’t respond to standard treatments
Medical Xpress
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved by the Food and Drug …
Thumbs Up to Latest CAR T-Cell ApprovalMedPage Today
For Some, Cutting-Edge ‘CAR-T’ Treatment Unleashes ‘Pac-Man’ Cells Against Blood CancerWBUR

all 7 news articles »